277 related articles for article (PubMed ID: 23453463)
1. Optimising the design and operation of semi-continuous affinity chromatography for clinical and commercial manufacture.
Pollock J; Bolton G; Coffman J; Ho SV; Bracewell DG; Farid SS
J Chromatogr A; 2013 Apr; 1284():17-27. PubMed ID: 23453463
[TBL] [Abstract][Full Text] [Related]
2. Improving affinity chromatography resin efficiency using semi-continuous chromatography.
Mahajan E; George A; Wolk B
J Chromatogr A; 2012 Mar; 1227():154-62. PubMed ID: 22265178
[TBL] [Abstract][Full Text] [Related]
3. Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins.
Godawat R; Brower K; Jain S; Konstantinov K; Riske F; Warikoo V
Biotechnol J; 2012 Dec; 7(12):1496-508. PubMed ID: 23070975
[TBL] [Abstract][Full Text] [Related]
4. A safe, effective, and facility compatible cleaning in place procedure for affinity resin in large-scale monoclonal antibody purification.
Wang L; Dembecki J; Jaffe NE; O'Mara BW; Cai H; Sparks CN; Zhang J; Laino SG; Russell RJ; Wang M
J Chromatogr A; 2013 Sep; 1308():86-95. PubMed ID: 23953712
[TBL] [Abstract][Full Text] [Related]
5. Transfer of a three step mAb chromatography process from batch to continuous: Optimizing productivity to minimize consumable requirements.
Gjoka X; Gantier R; Schofield M
J Biotechnol; 2017 Jan; 242():11-18. PubMed ID: 27939321
[TBL] [Abstract][Full Text] [Related]
6. Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture.
Pollock J; Coffman J; Ho SV; Farid SS
Biotechnol Prog; 2017 Jul; 33(4):854-866. PubMed ID: 28480535
[TBL] [Abstract][Full Text] [Related]
7. A tandem laboratory scale protein purification process using Protein A affinity and anion exchange chromatography operated in a weak partitioning mode.
Shamashkin M; Godavarti R; Iskra T; Coffman J
Biotechnol Bioeng; 2013 Oct; 110(10):2655-63. PubMed ID: 23633385
[TBL] [Abstract][Full Text] [Related]
8. Twin-column CaptureSMB: a novel cyclic process for protein A affinity chromatography.
Angarita M; Müller-Späth T; Baur D; Lievrouw R; Lissens G; Morbidelli M
J Chromatogr A; 2015 Apr; 1389():85-95. PubMed ID: 25748537
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of using continuous chromatography in downstream processing: Comparison of costs and product quality for a hybrid process vs. a conventional batch process.
Ötes O; Flato H; Winderl J; Hubbuch J; Capito F
J Biotechnol; 2017 Oct; 259():213-220. PubMed ID: 28684321
[TBL] [Abstract][Full Text] [Related]
10. Evaluating end-to-end continuous antibody manufacture with column-free capture alternatives from economic, environmental, and robustness perspectives.
Neves CPG; Coffman JL; Farid SS
Biotechnol Prog; 2024 Jan; ():e3427. PubMed ID: 38289674
[TBL] [Abstract][Full Text] [Related]
11. Design of high productivity antibody capture by protein A chromatography using an integrated experimental and modeling approach.
Ng CK; Osuna-Sanchez H; Valéry E; Sørensen E; Bracewell DG
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jun; 899():116-26. PubMed ID: 22658737
[TBL] [Abstract][Full Text] [Related]
12. Comparison of batch and continuous multi-column protein A capture processes by optimal design.
Baur D; Angarita M; Müller-Späth T; Steinebach F; Morbidelli M
Biotechnol J; 2016 Jul; 11(7):920-31. PubMed ID: 26992151
[TBL] [Abstract][Full Text] [Related]
13. Integrated continuous production of recombinant therapeutic proteins.
Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
[TBL] [Abstract][Full Text] [Related]
14. Process cost and facility considerations in the selection of primary cell culture clarification technology.
Felo M; Christensen B; Higgins J
Biotechnol Prog; 2013; 29(5):1239-45. PubMed ID: 23847160
[TBL] [Abstract][Full Text] [Related]
15. Fed-batch and perfusion culture processes: economic, environmental, and operational feasibility under uncertainty.
Pollock J; Ho SV; Farid SS
Biotechnol Bioeng; 2013 Jan; 110(1):206-19. PubMed ID: 22806692
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of new affinity chromatography resins for polyclonal, oligoclonal and monoclonal antibody pharmaceuticals.
Ishihara T; Nakajima N; Kadoya T
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Aug; 878(23):2141-4. PubMed ID: 20591751
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of high-capacity cation exchange chromatography for direct capture of monoclonal antibodies from high-titer cell culture processes.
Tao Y; Ibraheem A; Conley L; Cecchini D; Ghose S
Biotechnol Bioeng; 2014 Jul; 111(7):1354-64. PubMed ID: 24420791
[TBL] [Abstract][Full Text] [Related]
18. A straightforward methodology for designing continuous monoclonal antibody capture multi-column chromatography processes.
Gjoka X; Rogler K; Martino RA; Gantier R; Schofield M
J Chromatogr A; 2015 Oct; 1416():38-46. PubMed ID: 26363944
[TBL] [Abstract][Full Text] [Related]
19. End-to-end continuous bioprocessing: Impact on facility design, cost of goods, and cost of development for monoclonal antibodies.
Mahal H; Branton H; Farid SS
Biotechnol Bioeng; 2021 Sep; 118(9):3468-3485. PubMed ID: 33792918
[TBL] [Abstract][Full Text] [Related]
20. Exploration of overloaded cation exchange chromatography for monoclonal antibody purification.
Liu HF; McCooey B; Duarte T; Myers DE; Hudson T; Amanullah A; van Reis R; Kelley BD
J Chromatogr A; 2011 Sep; 1218(39):6943-52. PubMed ID: 21871630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
